Teladoc Health Reports Second-Quarter 2022 Results

Go back to Teladoc Health Reports Second-Quarter 2022 Results

Teladoc (TDOC) PT Lowered to $40 at JPMorgan, 'We expect the stock to be a show-me story in the near term'

July 28, 2022 12:26 PM EDT

JPMorgan analyst Lisa Gill lowered the price target on Teladoc (NYSE: TDOC) to $40.00 (from $53.00) while maintaining a Neutral rating.

The analyst comments "We highlight a significant market opportunity for telehealth services, which helps to solve two key issues affecting the... More

Teladoc (TDOC) Misses Q2 EPS

July 27, 2022 4:07 PM EDT

Teladoc (NYSE: TDOC) reported Q2 EPS of ($19.22), which may not compare to the analyst estimate of ($0.64). Revenue for the quarter came in at $592.4 million versus the consensus estimate of $587.71 million.

GUIDANCE:

Teladoc sees Q3 2022 EPS of ($0.85)-($0.60), versus the consensus... More